Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty

NCT01467882 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT01467882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01467882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty
Lead sponsor
Debiopharm International SA
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2012
Completion date
July 31, 2014
Enrollment
44 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

central precocious puberty